Exact Mass: 640.3224

N1,N5,N10-Tris-trans-p-coumaroylspermine

C37H44N4O6 (640.3261)

N1,N5,N10-Tris-trans-p-coumaroylspermine is found in herbs and spices. It is a constituent of Matricaria chamomilla (German chamomile). Constituent of Matricaria chamomilla (German chamomile). N1,N5,N10-Tris-trans-p-coumaroylspermine is found in herbs and spices.

PA(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C33H53O10P (640.3376)

PA(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Resolvin D5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0)

C33H53O10P (640.3376)

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0), in particular, consists of one chain of one Resolvin D5 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C33H53O10P (640.3376)

PA(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Protectin DX at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0)

C33H53O10P (640.3376)

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0), in particular, consists of one chain of one Protectin DX at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Alpindenoside B

C32H48O13 (640.3095)

Scupontin D

C32H48O13 (640.3095)

12-O-Methylnimbolinin B

C36H48O10 (640.3247)

Scortechinone S

C35H44O11 (640.2883)

Moluccensin A

C35H44O11 (640.2883)

Moluccensin F

C35H44O11 (640.2883)

23-Galloylarjunolic acid

C37H52O9 (640.3611)

Ixerisoside K

C31H44O14 (640.2731)

Crooksiine

C36H40N4O7 (640.2897)

Chenabinol methyl ether

C38H44N2O7 (640.3148)

(+)-thalirugine|Thalirugine

C38H44N2O7 (640.3148)

malavanin E

C35H44O11 (640.2883)

linifolin b

C36H48O10 (640.3247)

cucurbitacin E 2,16-diacetate

C36H48O10 (640.3247)

Resibufogenin-3-succinoylargininester

C34H48N4O8 (640.3472)

1beta,2beta,3,beta4,beta,5beta-pentahydroxy-spiro-25(27)-en-5-O-beta-D-glucopyranoside|Aspidoside A

C33H52O12 (640.3459)

anzurogenin C 24-O-beta-D-glucopyranoside (anzuroside)

C33H52O12 (640.3459)

Myrsinoltype diterpene ester CPB51-719-1

C35H44O11 (640.2883)

(18R,19S)-phorbaside|phorbaside A

C33H49ClO10 (640.3014)

Norcimiciphytine

C36H40N4O7 (640.2897)

coronalactoside I

C32H48O13 (640.3095)

(1R,3E,8E,10R,13S)-9.10,13-tris(acetoxy)-2,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethylbicyclo[9.3.1]pentadeca-3,8,11-trien-5-yl (2E)-3-phenylprop-2-enoate|(3E,8E)-9,10beta,13alpha-triacetoxy-2alpha,7beta,20-trihydroxy-5alpha-[(2E)-cinnamoyloxy]-3,8-secotaxa-3,8,11-triene

C35H44O11 (640.2883)

C33H52O12

C33H52O12 (640.3459)

1beta,2beta,3,beta4,beta,5beta,7alpha-hexaol-spirost-25(27)-en-6-one-4-O-beta-D-xylopyranoside|tupisteroide A

C32H48O13 (640.3095)

(2E,5E)-7-hydroperoxy-3,7-dimethyl-2,5-octadienyl-O-(alpha-L-rhamnopyranosyl)-(1??3?)-(4??-O-trans-p-coumaroyl)-beta-D-glucopyranoside|liguroside A

C31H44O14 (640.2731)

3beta-benzoyloxy-5alpha,8alpha-diacetoxy-15beta-hydroxy-7beta-isobutanoyloxyjatropha-6(17),11E-diene-9,14-dione

C35H44O11 (640.2883)

3beta-benzoyloxy-7beta-n-butanoyloxy-5alpha,8alpha-diacetoxy-15beta-hydroxyjatropha-6(17),11E-diene-9,14-dione

C35H44O11 (640.2883)

pierisformotoxin A|rel-(3aR,4S,4aS,7S,8R,9S,9aR,10R,11S,11aR,12S)-8,9,10,11-tetrakis(acetyloxy)decahydro-4-hydroxy-11a-(1-hydroxy-1-methylethyl)-4,8-dimethyl-12-(1-oxopropoxy)-4H-7,9a-methanoheptaleno[3,2-b]furan-2(3H)-one

C31H44O14 (640.2731)

(2S,3S,4R,5R,7R,9S,11S,15R)-5,15-diacetoxy-3,7-dibenzoyloxy-14-oxolathyra-6(17),12E-diene|euphorbia factor L2

C39H44O8 (640.3036)

pierisformotoxin B|rel-(3aR,4S,4aS,7S,8R,9S,9aR,10R,11S,11aR,12S)-8,9,11,12-tetrakis(acetyloxy)decahydro-4-hydroxy-11a-(1-hydroxy-1-methylethyl)-4,8-dimethyl-10-(1-oxopropoxy)-4 H-7,9a-methanoheptaleno[3,2-b]furan-2(3H)-one

C31H44O14 (640.2731)

milbemycin alpha21

C37H52O9 (640.3611)

4,5-dioxo-4,5-secopheophorbide a methyl ester

C36H40N4O7 (640.2897)

kidjoranin 3-O-beta-D-digitoxopyranoside|kidjoranin 3-O-beta-digitoxopyranoside

C36H48O10 (640.3247)

violide K

C32H48O13 (640.3095)

2-[4-(beta-D-glucopyranosyloxy)-3-hydroxy-2,5-bis(3-methylbut-2-en-1-yl)phenyl]-2-[(3-hydroxy-5-methoxy-3-methyl-5-oxopentanoyl)oxy]acetic acid|sabphenoside C

C31H44O14 (640.2731)

(+)-maroumine

C37H40N2O8 (640.2785)

Glu Lys Leu Thr His

C28H48N8O9 (640.3544)

Arg Phe Tyr Arg

C30H44N10O6 (640.3445)

Phe Lys Glu Ala Phe

C32H44N6O8 (640.322)

Ingol 7,8,12-triacetate 3-(4-methoxyphenyl)acetate

C35H44O11 (640.2883)

oxetanabeodendroidin X

C35H44O11 (640.2883)

Phe Arg Arg Tyr

C30H44N10O6 (640.3445)

Phe Arg Tyr Arg

C30H44N10O6 (640.3445)

Phe Tyr Arg Arg

C30H44N10O6 (640.3445)

His Ile Trp Trp

C34H40N8O5 (640.3122)

His Leu Trp Trp

C34H40N8O5 (640.3122)

His Trp Ile Trp

C34H40N8O5 (640.3122)

His Trp Leu Trp

C34H40N8O5 (640.3122)

His Trp Trp Ile

C34H40N8O5 (640.3122)

His Trp Trp Leu

C34H40N8O5 (640.3122)

Ile His Trp Trp

C34H40N8O5 (640.3122)

Ile Trp His Trp

C34H40N8O5 (640.3122)

Ile Trp Trp His

C34H40N8O5 (640.3122)

Leu His Trp Trp

C34H40N8O5 (640.3122)

Leu Trp His Trp

C34H40N8O5 (640.3122)

Leu Trp Trp His

C34H40N8O5 (640.3122)

Arg Phe Arg Tyr

C30H44N10O6 (640.3445)

Arg Arg Phe Tyr

C30H44N10O6 (640.3445)

Arg Arg Tyr Phe

C30H44N10O6 (640.3445)

Arg Tyr Phe Arg

C30H44N10O6 (640.3445)

Arg Tyr Arg Phe

C30H44N10O6 (640.3445)

Trp His Ile Trp

C34H40N8O5 (640.3122)

Trp His Leu Trp

C34H40N8O5 (640.3122)

Trp His Trp Ile

C34H40N8O5 (640.3122)

Trp His Trp Leu

C34H40N8O5 (640.3122)

Trp Ile His Trp

C34H40N8O5 (640.3122)

Trp Ile Trp His

C34H40N8O5 (640.3122)

Trp Leu His Trp

C34H40N8O5 (640.3122)

Trp Leu Trp His

C34H40N8O5 (640.3122)

Trp Trp His Ile

C34H40N8O5 (640.3122)

Trp Trp His Leu

C34H40N8O5 (640.3122)

Trp Trp Ile His

C34H40N8O5 (640.3122)

Trp Trp Leu His

C34H40N8O5 (640.3122)

Tyr Phe Arg Arg

C30H44N10O6 (640.3445)

Tyr Arg Phe Arg

C30H44N10O6 (640.3445)

Tyr Arg Arg Phe

C30H44N10O6 (640.3445)

FKEAF

C32H44N6O8 (640.322)

N1,N5,N10-Tris-trans-p-coumaroylspermine

C37H44N4O6 (640.3261)

PHHdiA-PG

C29H53O13P (640.3224)

catechin(3,4,5,7-tetraacetate)-3-dodecanoate

C35H44O11 (640.2883)

Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro-Ala)

C25H40N10O10 (640.2929)

Fmoc-Lys(Mtt)-OH

C41H40N2O5 (640.2937)

Fmoc-Lys(MMt)-OH

C41H40N2O5 (640.2937)

3-butyl-2-[3-(3-butyl-1,1-dimethylbenzo[e]indol-3-ium-2-yl)prop-2-enylidene]-1,1-dimethylbenzo[e]indole,perchlorate

C39H45ClN2O4 (640.3068)

N,N,N,N-Tetraphenyl-1,1:4,1:4,1-quaterphenyl-4,4-di amine

C48H36N2 (640.2878)

2,2-Methylene Bis[Ranitidine]

C27H44N8O6S2 (640.2825)

Dansyl-NECA

C30H40N8O6S (640.2791)

1(2H)-Phthalazinone, 4-((4-chlorophenyl)methyl)-2-(((2R)-1-(4-(4-(3-(hexahydro-1H-azepin-1-yl)propoxy)phenyl)butyl)-2-pyrrolidinyl)methyl)-

C39H49ClN4O2 (640.3544)

(Arachidoyl)adenylate

C30H51N5O8P- (640.3475)

5-carboxysalinisporamycin A

C34H42NO11- (640.2758)

3-[(21S,22S)-12-(dihydroxymethyl)-26-ethyl-4-hydroxy-16-(1-hydroxyethyl)-17,19,21-trimethyl-11-(2-methylpropyl)-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

C37H44N4O6 (640.3261)

PA(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C33H53O10P (640.3376)

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0)

C33H53O10P (640.3376)

PA(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C33H53O10P (640.3376)

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0)

C33H53O10P (640.3376)

Euphorbia diterpenoid 1

C35H44O11 (640.2883)

A tetracyclic diterpenoid isolated from the whole plant of Euphorbia decipiens and exhibits inhibitory activity against prolyl endopeptidase (EC 3.4.21.26).

Kidjoranin-3-O-beta-digitoxopyranoside

C36H48O10 (640.3247)

A steroid glycoside isolated from the roots of Cynanchum auriculatum and has been shown to exhibit cytotoxicity against human tumour cell lines. Kidjoranin-3-O-beta-digitoxopyranoside is a steroid glycoside isolated from the roots of Cynanchum auriculatum and has been shown to exhibit cytotoxicity against human tumour cell lines. It has a role as a metabolite and an antineoplastic agent. It is a 17beta-hydroxy steroid, a cinnamate ester, a methyl ketone, a deoxy hexoside, a steroid ester, a steroid saponin and a tertiary alpha-hydroxy ketone. It derives from a hydride of a pregnane.

3-oxo-5alpha-androstan-17beta-yl 2-O-beta-D-glucopyranuronosyl-beta-D-glucopyranosiduronate

C31H44O14-2 (640.2731)

Ac-Gln-D-Phe-His-D-Pro-betaAla

C30H40N8O8 (640.2969)

1-(4-fluorophenyl)-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea

C37H41FN4O5 (640.3061)

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (Z)-henicos-11-enoate

C30H57O12P (640.3587)

Dgdg O-9:0_6:0

C30H56O14 (640.367)

Dgdg O-8:0_7:0

C30H56O14 (640.367)

Smgdg O-16:1_5:0

C30H56O12S (640.3492)

Smgdg O-19:1_2:0

C30H56O12S (640.3492)

Smgdg O-13:1_8:0

C30H56O12S (640.3492)

Smgdg O-14:1_7:0

C30H56O12S (640.3492)

Smgdg O-15:1_6:0

C30H56O12S (640.3492)

Smgdg O-18:1_3:0

C30H56O12S (640.3492)

Smgdg O-17:1_4:0

C30H56O12S (640.3492)

Smgdg O-8:0_13:1

C30H56O12S (640.3492)

Dgdg O-12:0_3:0

C30H56O14 (640.367)

Dgdg O-10:0_5:0

C30H56O14 (640.367)

Dgdg O-11:0_4:0

C30H56O14 (640.367)

Dgdg O-13:0_2:0

C30H56O14 (640.367)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C33H53O10P (640.3376)

[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] nonanoate

C29H52O15 (640.3306)

[2-Heptanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] heptanoate

C29H52O15 (640.3306)

[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] octanoate

C29H52O15 (640.3306)

[1-Acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] dodecanoate

C29H52O15 (640.3306)

[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] undecanoate

C29H52O15 (640.3306)

[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] decanoate

C29H52O15 (640.3306)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-heptadec-9-enoate

C29H53O13P (640.3224)

[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C29H53O13P (640.3224)

[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C29H53O13P (640.3224)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-pentadec-9-enoate

C29H53O13P (640.3224)

[1-heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate

C29H53O13P (640.3224)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C33H53O10P (640.3376)

[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-octadec-9-enoate

C29H53O13P (640.3224)

[(2S,3S,6S)-6-[(2S)-2-decanoyloxy-3-undecanoyloxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C30H56O12S (640.3492)

[(2S,3S,6S)-6-[(2S)-3-decanoyloxy-2-undecanoyloxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C30H56O12S (640.3492)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C33H53O10P (640.3376)

SMGDG O-20:2;O

C29H52O13S (640.3128)

SMGDG O-21:1

C30H56O12S (640.3492)

SQDG 20:1;O

C29H52O13S (640.3128)

SQDG 21:0

C30H56O12S (640.3492)

DGMG 15:0

C30H56O14 (640.367)

DGGA 24:4;O

C33H52O12 (640.3459)

PA 18:3/12:3;O2

C33H53O10P (640.3376)

PA 18:4/11:3;O3

C32H49O11P (640.3012)

PA 18:4/12:2;O2

C33H53O10P (640.3376)

PA 22:4/7:3;O3

C32H49O11P (640.3012)

PA 22:4/8:2;O2

C33H53O10P (640.3376)

PA 22:5/7:2;O3

C32H49O11P (640.3012)

PA 22:5/8:1;O2

C33H53O10P (640.3376)

PA 29:7;O3

C32H49O11P (640.3012)

PA 30:6;O2

C33H53O10P (640.3376)

LPGP 22:4

C28H50O12P2 (640.2777)

PG O-16:0/8:2;O3

C30H57O12P (640.3587)

PG O-24:2;O3

C30H57O12P (640.3587)

PG 16:0/7:2;O3

C29H53O13P (640.3224)

PG 16:0/8:1;O2

C30H57O12P (640.3587)

PG 18:4/8:3;O

C32H49O11P (640.3012)

PG 20:0/4:1;O2

C30H57O12P (640.3587)

PG 20:5/6:2;O

C32H49O11P (640.3012)

PG 22:6/4:1;O

C32H49O11P (640.3012)

PG 24:1;O2

C30H57O12P (640.3587)

PG 26:7;O

C32H49O11P (640.3012)

LPI 21:1

C30H57O12P (640.3587)

PI O-20:2;O

C29H53O13P (640.3224)

PI P-16:0/4:1;O

C29H53O13P (640.3224)

LPI 20:2;O

C29H53O13P (640.3224)

PI 14:1/5:1;O

C28H49O14P (640.286)

PI 19:2;O

C28H49O14P (640.286)

PI 16:0/4:1

C29H53O13P (640.3224)

PI 16:1/4:0

C29H53O13P (640.3224)

PI 18:1/2:0

C29H53O13P (640.3224)

PI 20:1

C29H53O13P (640.3224)

PI 2:0_18:1

C29H53O13P (640.3224)

ST 25:4;O8;GlcA

C31H44O14 (640.2731)

ST 26:3;O7;GlcA

C32H48O13 (640.3095)

ST 27:2;O6;GlcA

C33H52O12 (640.3459)

ST 26:4;O8;Hex

C32H48O13 (640.3095)

ST 27:3;O7;Hex

C33H52O12 (640.3459)

6-(furan-3-yl)-17-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-13-yl 2-methylpropanoate

C35H44O11 (640.2883)

(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14br)-10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(3,4,5-trihydroxybenzoyloxy)methyl]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H52O9 (640.3611)

(1s,4s,12r,16s)-9-[(5r,9r,16r)-14,16-dihydroxy-6-methyl-2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl]-7-hydroxy-8-methoxy-5-methyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-2,6,8,10-tetraen-18-one

C36H40N4O7 (640.2897)

(1s,2r,5r,6r,13r,14s,15s,17r,18s)-6-(furan-3-yl)-13-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-17-yl 2-methylpropanoate

C35H44O11 (640.2883)

(2z)-4-[(1r,2r,7s,14s,15s,16s,18s)-11-hydroxy-10-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-15,16-dimethoxy-6,6,7,20,20-pentamethyl-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4(12),5(9),10-trien-18-yl]-2-methylbut-2-enoic acid

C35H44O11 (640.2883)

(2s)-4-[(1r,3r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5r,6ar)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl (3s)-3-(acetyloxy)butanoate

C32H48O13 (640.3095)

4-[(2s,6as,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

9-{14,16-dihydroxy-6-methyl-2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl}-8-hydroxy-7-methoxy-5-methyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-2,6(11),7,9-tetraen-18-one

C36H40N4O7 (640.2897)

aspidoside a

C33H52O12 (640.3459)

{"Ingredient_id": "HBIN017153","Ingredient_name": "aspidoside a","Alias": "NA","Ingredient_formula": "C33H52O12","Ingredient_Smile": "CC1C2C(CC3C2(CCC4C3CCC5(C4(C(C(C(C5O)O)O)O)C)OC6C(C(C(C(O6)CO)O)O)O)C)OC17CCC(=C)CO7","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1902","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,2r,5r,6r,13r,14s,15s,17r,18s)-6-(furan-3-yl)-17-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-13-yl 2-methylpropanoate

C35H44O11 (640.2883)

3-(8-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl)-5h-furan-2-one

C32H48O13 (640.3095)

(1s)-1-{[4-(5-{[(1s)-7-hydroxy-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl}-2-methoxyphenoxy)phenyl]methyl}-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-5-ol

C38H44N2O7 (640.3148)

(1r,2r,6s,8r,11r,12s,13r,16r,17r,19s,20r)-17,19-bis(acetyloxy)-8-(furan-3-yl)-4-methoxy-1,9,11,16-tetramethyl-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-12-yl (2e)-2-methylbut-2-enoate

C36H48O10 (640.3247)

(1r)-5-(4-{[(1r)-6-hydroxy-7-methoxy-8-[(6-methoxy-2-methyl-1-oxo-3,4-dihydroisoquinolin-7-yl)oxy]-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl}phenoxy)-4-methoxycyclohexa-2,4-diene-1-carbaldehyde

C37H40N2O8 (640.2785)

(1r,2r,4r,6s,8r,11r,12s,13r,16r,17r,19s,20r)-17,19-bis(acetyloxy)-8-(furan-3-yl)-4-methoxy-1,9,11,16-tetramethyl-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-12-yl (2e)-2-methylbut-2-enoate

C36H48O10 (640.3247)

1-acetyl-7-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-1,3a,3b-trihydroxy-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl 3-phenylprop-2-enoate

C36H48O10 (640.3247)

(1s,2r,3s,4s,7s,8z,10s,11r,12r,13s,16r,17s)-2,12-bis(acetyloxy)-3,4,11,16,17-pentahydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,14-dien-10-yl octanoate

C32H48O13 (640.3095)

(2s)-4-[(1r,3r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6as)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl (3s)-3-(acetyloxy)butanoate

C32H48O13 (640.3095)

5-carbamimidamido-2-[(4-{[7,11-dimethyl-6-(6-oxopyran-3-yl)-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-14-yl]oxy}-1-hydroxy-4-oxobutylidene)amino]pentanoic acid

C34H48N4O8 (640.3472)

methyl 2-[(1s,2s,4ar,5r,8s,8as)-1,8-dihydroxy-5-{[(2r)-2-hydroxy-3-(4-hydroxyphenyl)propanoyl]oxy}-4a-methyl-8-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-octahydronaphthalen-2-yl]prop-2-enoate

C31H44O14 (640.2731)

4-(8-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl)-5h-furan-2-one

C32H48O13 (640.3095)

5-[4-({6-hydroxy-7-methoxy-8-[(6-methoxy-2-methyl-1-oxo-3,4-dihydroisoquinolin-7-yl)oxy]-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl}methyl)phenoxy]-4-methoxycyclohexa-2,4-diene-1-carbaldehyde

C37H40N2O8 (640.2785)

(2s)-4-[(1r,3r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5s,6ar)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl (3s)-3-(acetyloxy)butanoate

C32H48O13 (640.3095)

4-[(2r,6as,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(3,4,5-trihydroxybenzoyloxy)methyl]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H52O9 (640.3611)

9,10,13-tris(acetyloxy)-2,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethylbicyclo[9.3.1]pentadeca-3,8,11-trien-5-yl 3-phenylprop-2-enoate

C35H44O11 (640.2883)

(2s,3s,4r,5r,6s)-4,5-dihydroxy-6-[(2r)-2-hydroxy-3-[(13-methyltetradecyl)oxy]propoxy]-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid

C30H56O14 (640.367)

(2s)-5-carbamimidamido-2-[(4-{[(1r,2s,4r,6r,7r,10s,11s,14s,16r)-7,11-dimethyl-6-(6-oxopyran-3-yl)-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-14-yl]oxy}-1-hydroxy-4-oxobutylidene)amino]pentanoic acid

C34H48N4O8 (640.3472)

4,5-dihydroxy-6-{2-hydroxy-3-[(13-methyltetradecyl)oxy]propoxy}-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid

C30H56O14 (640.367)

9-{14,16-dihydroxy-6-methyl-2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl}-7-hydroxy-8-methoxy-5-methyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-2,6,8,10-tetraen-18-one

C36H40N4O7 (640.2897)

(1s,2r,3e,5r,7s,8e,10s,13r)-9,10,13-tris(acetyloxy)-2,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethylbicyclo[9.3.1]pentadeca-3,8,11-trien-5-yl (2e)-3-phenylprop-2-enoate

C35H44O11 (640.2883)

(1s,2r,5r,6r,13r,14s,15r,17r,18s)-6-(furan-3-yl)-13-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-17-yl 2-methylpropanoate

C35H44O11 (640.2883)

6-ethyl-21',24'-dihydroxy-5,11',13'-trimethyl-2'-oxo-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-10',14',16',22'-tetraen-22'-ylmethyl 2-methylbut-2-enoate

C37H52O9 (640.3611)

2-(4-{[(1s)-7-[(6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-8-yl)oxy]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl}phenoxy)-4-(methoxymethyl)phenol

C38H44N2O7 (640.3148)

(1s,2r,5s,6s,13s,14r,17r,18s)-6-(furan-3-yl)-13-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-17-yl 2-methylpropanoate

C35H44O11 (640.2883)

methyl 2-(1,8-dihydroxy-5-{[2-hydroxy-3-(4-hydroxyphenyl)propanoyl]oxy}-4a-methyl-8-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-octahydronaphthalen-2-yl)prop-2-enoate

C31H44O14 (640.2731)

4-[(2r,6ar,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

(1s,3ar,3bs,7s,9ar,9br,11r,11as)-1-acetyl-7-{[(2r,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3a,3b-trihydroxy-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-3-phenylprop-2-enoate

C36H48O10 (640.3247)

(1'r,2r,4's,5s,6r,8'r,10'e,13'r,14'e,16'e,20'r,21'r,24's)-6-ethyl-21',24'-dihydroxy-5,11',13'-trimethyl-2'-oxo-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-10',14',16',22'-tetraen-22'-ylmethyl (2e)-2-methylbut-2-enoate

C37H52O9 (640.3611)

3-[(2r,6ar,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

4-[11-hydroxy-10-(2-hydroxy-3-methylbut-3-en-1-yl)-15,16-dimethoxy-6,6,7,20,20-pentamethyl-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4(12),5(9),10-trien-18-yl]-2-methylbut-2-enoic acid

C35H44O11 (640.2883)

(1s,2r,5r,6r,13r,14s,15r,17r,18s)-6-(furan-3-yl)-17-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-13-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-14-yl 2-methylpropanoate

C35H44O11 (640.2883)

(1s,4r,12r,16s)-9-[(5r,9r,16r)-14,16-dihydroxy-6-methyl-2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl]-8-hydroxy-7-methoxy-5-methyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-2,6(11),7,9-tetraen-18-one

C36H40N4O7 (640.2897)

(2z)-4-[(1r,2r,7r,14s,15s,16s,18s)-11-hydroxy-10-(2-hydroxy-3-methylbut-3-en-1-yl)-15,16-dimethoxy-6,6,7,20,20-pentamethyl-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4(12),5(9),10-trien-18-yl]-2-methylbut-2-enoic acid

C35H44O11 (640.2883)

4-[(2s,6ar,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

4-[8-(acetyloxy)-3-hydroxy-5-{5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl}-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl 3-(acetyloxy)butanoate

C32H48O13 (640.3095)

(1s,2r,5s,6s,13s,14r,17r,18s)-6-(furan-3-yl)-17-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-13-yl 2-methylpropanoate

C35H44O11 (640.2883)

6-(furan-3-yl)-13-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-17-yl 2-methylpropanoate

C35H44O11 (640.2883)

1-(2-{[2-(acetyloxy)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-(4-hydroxyphenyl)butanoyl)-n-(5-carbamimidamido-1-hydroxypentan-2-yl)pyrrolidine-2-carboximidic acid

C32H44N6O8 (640.322)

(1s,4r,12r,16s)-9-[(5r,9r,16r)-14,16-dihydroxy-6-methyl-2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl]-7-hydroxy-8-methoxy-5-methyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-2,6,8,10-tetraen-18-one

C36H40N4O7 (640.2897)

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-4,8,9-tris(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-13-yl 2-(4-methoxyphenyl)acetate

C35H44O11 (640.2883)

(1r,3r,4s,5r,6s,7s,9r,10s,11s,12s,13s,14s,15r,23s,25r)-3,10,11-trihydroxy-9-(hydroxymethyl)-13,15-dimethyl-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-12-yl benzoate

C36H48O10 (640.3247)

3,10,11-trihydroxy-9-(hydroxymethyl)-13,15-dimethyl-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-12-yl benzoate

C36H48O10 (640.3247)

3-[(2s,6ar,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)